Company Overview

PRIME exits and American HealthCare Capital are pleased to exclusively represent a Substance Use and Co-Occurring Disorder Detox and Treatment Center with multiple locations in the Western US. With a total of 14 beds, the facilities serve a diverse clientele, including adults aged 18 to 70+, encompassing professionals, executives, and individuals seeking their first treatment experience. Clients come from across the United States and internationally.

Financial Overview

The company’s payer mix is 60% out of network insurance, 30% private pay, and 10% in network insurance. They are currently in the process of applying for in network status with multiple insurances. The company has seen consistent growth since its inception. In 2024, they grossed a total of $4 million. In 2025, they expect to exceed $5 million in gross revenue with an adjusted EBITDA of approximately $1.5 million.

Staff Overview and Exit Plan

Each facility is fully equipped with a full team of clinicians and support staff. However, billing, HR, admissions, and executive management are centralized. The seller would like to like to take a step back to spend more time with family and is seeking a buyer who can take the company to the next level. The seller is open to staying on in a part time or consulting role if desired.

Asking Price

The asking price for this opportunity is $7.5 million. This does not include any cash, receivables, working capital, or real estate.

The real estate associated with the facilities is available for sale as well if desired.